Table 4. Cases of malaria among 2004 ill returned travellers with a travel-related diagnosis, by purpose of travel.
Type of malaria; no. of cases | |||||||||
---|---|---|---|---|---|---|---|---|---|
Reason for travel | Total cases | P. falciparum | Severe or cerebral malaria | P. vivax | P. ovale | Plasmo-dium species unknown | Top three‡ countries of exposure | Obtained pre-travel advice | Received prophy-laxis |
All (n = 2004) | 51 | 30 | 1 | 12 | 2 | 6 | See Table 3 | 10 (19.6) | 3† |
Tourism (n = 883) | 3 | 2 | 0 | 0 | 0 | 1 | Gabon, Ghana, Thailand | 2 (66.7) | 0 |
Immigration (n = 493) | 6 | 2 | 0 | 4 | 0 | 0 | India, Afghanistan, Nigeria, Gabon | N/A | N/A |
Visit friends and relatives (n = 206) | 21 | 12 | 0 | 8 | 0 | 1 | India, Pakistan, Nigeria | 3 (14.3) | 1 |
Missionary, volunteer, researcher, aid (n = 212) | 12 | 9 | 1 | 0 | 1 | 1 | Haiti, Ivory Coast, Cameroon | 3 (25.0) | 2 |
Business (n = 160) | 9 | 5 | 0 | 0 | 1 | 3 | Sierra Leone | 2 (22.2) | 0 |
Other* (n = 50) | 0 | 0 | 0 | 0 | 0 | 0 | N/A | N/A | N/A |
NA = not applicable, P. falciparum = Plasmodium falciparum. *Includes students (n = 42), military personnel (n = 6) and medical tourists (n = 2). †Includes two travellers who either missed doses of doxycycline throughout travel or ran out of doxycycline prior to the end of travel. ‡Where only one or two countries are listed, this indicates >three-way tie for second or third place.